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In the various studies  that have been done on the inhibition  of proteolytic 
enzymes by serum, no distinction has been made in the inhibition of different 
enzymes. It has generally been assumed that all proteolytic inhibition is caused 
by the  same  substance  in  serum  and  that  this  substance  is  occasionally in- 
creased in association with disease. There has been no evidence for the existence 
of separate proteolytic inhibitors.  There have been several attempts  to isolate 
the  material  in  serum  responsible  for  the  inhibition  of  proteolytic  enzymes 
(1,  2),  but no  inhibitory  material  has  yet been  obtained  in  pure  form.  The 
chemical characteristics of the inhibitory material in serum are not well known. 
The  data  t0 be presented  indicate  that  more than  one antiproteolytic  factor 
can be detected in serum and that these factors act selectively on the enzymes 
plasmin,  trypsin,  and  chymotrypsin.  For the  sake  of convenience,  the  factor 
in serum which inhibits an enzyme will be referred to as the enzyme inhibitor 
(e.g.,  plasm{n  inhibitor,  trypsin inhibitor),  although  each  inhibitor  maybe 
composed of several substances or groups of substances. 
Materials and Methods 
The materials used were the same as in Paper I. 
Measurement of Enzyme Aetivity.--Enzyme activity was determined  using the standard 
curves of digestion that were described in Paper I  (Figs. 1 to 3). 
Measurement of Enzyme Inkib4tion.--Measurement of serum inhibition  was done as de- 
scribed in the preceding paper. To measure inhibition by normal serum, a constant  amount 
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of serum was mixed with the largest amount of each enzyme on the standard digestion curves. 
The amount of serum used inhibited approximately 1/3 of this amount of enzyme. This per- 
mitted measurements to be made in the most sensitive region for detecting small variations 
in enzyme activity on the standard digestion curves. For plasmin, the amount of serum used 
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F[o. 1.  Inhibition of plasmin by serum from normal and diseased individuals. Description 
in text. Inhibition expressed as micrograms of phsmin inhibited by 1.65 X  10  -'a ml. of serum. 
was 1.65  X  10  -s ml. per 0.5 ml. of enzyme-serum mixture; for trypsin, 4.2  X  10  .4 ml.; and 
for chymotrypsin, 3.3  X  10  -8 ml. The same amount of abnormal serum was used. If an ab- 
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measurement. Various other inhibitory solutions were similarly diluted. N. RAPHAEL SHULMAN  595 
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FIG. 2.  Inhibition of trypsin by serum from normal and diseased individuals. Description 
in text. Inhibition expressed as micrograms of trypsin inhibited by 4.2  X  10  -4 ml. of Serum. 
RESULTS 
Inhibition of Plasmin, Trypsin,  and Chymotrypsin by Serum from Normal and 
Diseased Individuals 
The sera of 65 normal individuals  x  and the sera of 69 patients with cancer, 28 patients with 
various acute diseases,  and 20 patients with active tuberculosis were tested for inhibition of 
each enzyme.  (A description of the patients  is given in Paper  III.)  Results are shown in 
Figs.  1 to 3. 
With  plasmin,  the  2  sigma  variation  in  inhibition  by  normal  sera  was  44 
per cent of the mean value; for trypsin  it was 64 per cent of the mean; and for 
t  Normal sera were obtained from members of the house staff, nurses, and technicians at 
Memorial Hospital, and from donors at the Memorial Hospital Blood Bank. Blood was drawn 
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chymotrypsin it  was 34 per cent of the mean. These different  percentages are 
in  part  due to  error  inherent in  the  method of  measuring enzymes. As shown in 
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FIO.  3. Inhibition  of  chymotrypsin  by serum from normal and  diseased  individuals.  De- 
scription  in  text.  Inhibition  expressed  as  micrograms  of  chymotrypsin  inhibited  by 3.3 X 
I0  -~  ml.  of  serum. 
Paper I  this error differed somewhat for each enzyme, being greatest for tryp- 
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There  was  little  difference  between  the  inhibition  of plasmin  by  normal 
serum and by serum of diseased individuals (Fig. 1). In all 3 groups of diseases 
taken together  there  were  only 9  instances  in  which  plasmin  inhibition  was 
greater than the 2 sigma deviation for normal serum. Only 5 of the 9 showed 
greater inhibition than the highest normal serum; 2 from the cancer group, 2 
from the acute disease group, and 1 from the tuberculosis group. When these 
5  were  arbitrarily excluded,  the  mean value for inhibition  in each  group of 
diseases was the same as the mean for normal serum. 
With  trypsin  and  chymotrypsin the  results  were  quite  different  (Figs.  2 
and 3).  68 per cent of the acute disease sera, 59 per cent of the cancer sera, 
and 45 per cent of the tuberculosis sera showed significant increases in anti- 
proteolytic activity for both these enzymes. Increases in inhibition for trypsin 
and chymotrypsin were of equal magnitude  ia individual  sera.  Of the 5  sera 
in which plasmin inhibition was outside the range of normal, 2 had increased 
inhibition  for  trypsin  and  chymotrypsin and  3  did  not.  The  serum  sample 
with the highest inhibition  for plasmin  (tuberculosis  group)  was  1  of the  3 
which had normal inhibition  for trypsin and chymotrypsin. 
The fact that sera with increased inhibition  for trypsin and chymotrypsin 
showed no increased inhibition for plasmin; and that, in 3 instances, sera with 
increased  inhibition  for plasmin  showed no  increased  inhibition  for  trypsin 
and  chymotrypsin suggested  the  existence  of more  than  one proteolytic in- 
hibitor.  (For a discussion of the possible physiological significance of increased 
inhibition in serum see Paper III.) 
Properties of Inhlbitors in Normal Serum 
With the above evidence" that increases in proteolytic inhibition with disease 
were specific for different enzymes, the following procedures were carried out 
in order to determine whether normal serum also contained specific proteolytic 
inhibitors. 
1.  Differential Titration o/Inhibitors.--Titrations  were done by adding en- 
zyme to a  serum sample until  all the inhibitor for  that enzyme was used  up, 
and then adding a second enzyme to determine whether there was any inhibitor 
for it still present in the serum. 
Plasmin was added to a  fixed amount of serum in a  series of tubes. When the mixture of 
serum plus plasmin began to show increasing proteolytic activity on further  addition of 
enzyme, the plasmin-inhibiting factor in serum was considered to be completely neutralized. 
In Table I, the serum sample containing 70 3' of plasmin was taken as the end-point of such 
a titration.  Trypsin was then added in increasing amounts to a series of samples of this neu- 
tralized serum plasmin mixture to see if any inhibition for trypsin was still present, as shown 
in Table II. 
The amount of trypsin inhibited  by serum which  had been neutralized by 
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serum. There was no difference in the  amount of  trypsin inhibited when it 
was incubated with the serum plasmin mixture for as little as 20 or as long as 
TABLE I 
Titration of Serum with Plasmin 
Description in text.  Serum concentration constant at 2.25 X  10  -s ml. per 0.5 ml. of en- 
zyme-serum mixture. 
Plasmlnadded  Residual pla~ain activity 
-f 
30 
40 
50 
60 
70 
80 
90 
100 
140 
180 
"r 
0 
0 
0 
0 
0-5 
10 
17 
30 
75 
100 
TABLE II 
Inkibition of Trypsin by Strum Neutralized with Plasmin Compared with Inhibition  by 
Untreated Serum 
Description in text. One serum sample used throughout. The amount of trypsin inhibited 
by serum neutralized with plasmin as per cent of the amount of trypsin inhibited by un- 
treated serum is shown in the last column. 
Trypsin added 
3.00 
3.75 
4.50 
5.25 
6.00 
6.75 
1.13 X  10  t  ml. serum neu- 
tralized with 35~ plasmin 
Trypsin  Trypsin 
activity  inhibited 
0  All 
0.25  3.50 
0.95  3.55 
1.85  3.40 
2.50  3.50 
3.23  3.52 
1.13 X  l0 t ml. untreated 
serunl 
Trypsin  Trypsin 
activity  inhibited 
0  All 
0-0. i0  ,-, 3.7 
0.30  4.2 
1.35  3.90 
2.05  3.95 
2.70  4.05 
Comparison of inhibition 
By neutralized serum X  I00 
By untreated serum 
~er cent 
N  94.5 
84.5 
87.3 
88.4 
87.0 
100 minutes at room temperature. Results with chymotrypsin and the serum 
plasmin mixture were the same as those with trypsin. 
When the titration was carried out in reverse, that is, when trypsin or chymo- 
trypsin was added  to  the  serum until the first appearance of proteolytic ac- 
tivity,  and  then  plasmin  was  added,  no  inhibition for  plasmin  remained. 
When the neutralization was carried out first with trypsin,  no inhibition re- N. RAPHAEL  SIIULM.AN  599 
mained  for  chymotrypsin,  and  the  reverse  was  also  true.  It was possible  to 
rule  out  displacement  of  one  enzyme  by  the  other  from  combination  with 
inhibitor  by inspecting  the  shape  of the digestion  curves which were charac- 
teristic for each enzyme (see Figs. 7 to 9, Paper I). 
2.  Heat  Inactivation  of Inhibitors.--Heat  inactivation  was  found  to  be  a 
useful means of differentiating serum proteolytic inhibitors. 
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FIo. 4.  Heat inactivation  of inhibitors. Description in text. 
Portions  of undiluted  serum  were incubated  at 60°C. for various periods of time.  The 
amount of inhibition remaining for each enzyme in the heated  samples was compared to the 
amount of inhibition  in the unheated  controls. The results for plasmin and trypsin,  repre- 
senting  the averaged values for four different sera with each enzyme, are shown in Fig. 4. 
Results with chymotrypsin were the same as those with trypsin. 
The  inhibition  for  trypsin  and  chymotrypsin decreased  to  10  per  cent  of 
the original value in approximately 20 minutes at 60°C. while at the same time 
inhibition  for  plasmin  remained  practically  unchanged.  More  than  60  per 
cent of the inhibition for plasmin was still present  after 2 hours at 60°C. 
Serum inhibition  for all 3  enzymes was more stable  at 50°C.  After heating 
at 50°C. for 3  hours,  80 to 90 per cent of the inhibition  for each enzyme was 
still present. 
When  serum  was  diluted  ~o  with  M/15  phosphate  buffer,  pH  7.4,  prior 600  INIIJ-BITION  OF  PROTEOLYTIC  ]~NZYMES  BY  SERUm.  II 
to heating, the inhibition  for trypsin and chymotrypsin decreased only slightly 
more rapidly than in whole serum. The inhibition for plasmin decreased con- 
siderably more rapidly i~ diluted serum than it did in whole serum. It decreased 
to approximately 10 per cent after 40 minutes at 60°C. and then remained at 
this level with continued heating for as long as 2 hours. When diluted serum 
(~o)  was  heated  at  100°C.,  the  inhibition for  trypsin and  chymotrypsin 
decreased to approximately 5 per cent and the inhibition  for plasmin decreased 
to  approximately  10  per  cent within  10  minutes.  Some  inhibition for  all  3 
enzymes remained in measurable amounts, however,  even after  30  minutes 
of heating at 100°C. 
TABLE III 
Ammonium Sulfate Precipitation of Inhibitors 
Description in text. 
Ammonium sulfate concentration 
M 
1.25 
1.50 
1.75 
2.00 
2.25 
2.70 
3.00 
Per cent of total inhibition in precipitate of each 
fractionation 
Plasmin  inhibition 
~er Cen~ 
2.8 
5.7 
23.0 
67.2 
83.5 
100.0 
100.0 
Trypsin  inhibition 
~er Cetsg 
0 
i.4 
5.8 
il .4 
44.3 
94.0 
100.0 
3.  Ammonium Sulfate Precipitation of Inhibitors.--An  attempt was made to 
separate  the  different proteolytic inhibitors in serum by  ammonium sulfate 
fractionation. 
10 ml. portions of a pool of 10 sera were dialyzed against different volumes of saturated 
ammonium sulfate to vary the final salt concentration. Dialysis was carried out at 4°C. for 
36 hours with continuous agitation. The serum precipitates were separated by centrffugation 
and were washed 3 times with 5 ml. of ammonium sulfate at the concentration at which the 
precipitate  had formed. Each precipitate was resuspended in 5 ml. of washing solution and 
placed in a dialysis bag. The combined supernatant solution and washing solution of each 
precipitate were placed in another bag. They were dialyzed for 2 days at 4°C. against sufficient 
~¢/100 phosphate  buffer in physiological saline, pH 7.4, to bring the concentration of am- 
monium sulfate below 10  -4 molar. Ammonium sulfate, in the amounts present in the frac- 
tions after dialysis, was found to have no effect on the activity of any of the enzymes. 
For each enzyme a ratio was made of the inhibition  in the precipitate portion to the sum 
of the inhibition  in the precipitate plus supernatant portions to give the per cent of the total 
recovered inhibition  that was present in the precipitate. Results for piasmin and trypsin, repre- 
senting the average values for 3 separate fractionations at each concentration of ammonium 
sulfate,  are shown in Table III. Results with chymotrypsin were the same as those with 
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The  inhibitor for plasmin was precipitated  at  low  concentrations of am- 
monium sulfate; the inhibitor for trypsin and chymotrypsin was precipitated 
at higher concentrations. The best separation was in the 2 molar precipitate 
which contained 67 per cent of the plasmin inhibition and only 11 per cent of 
the trypsin and chymotrypsin inhibition. 
In the process of fractionation, 20 to 40 per cent of the original amount of 
inhibition for each enzyme was lost. In any one fractionation, the amounts 
of inhibition recovered for trypsin and chymotrypsin were equal to each other, 
but not necessarily equal to the amount recovered for plasmin. 
Properties of Inhibitors in Abnormal Serum 
It was shown above that abnormally high inhibition can occur for trypsin 
and chymotrypsin while inhibition for plasmin remains normal, and v/ce versa. 
The three abnormal serum samples showing the greatest increases in trypsin 
and chymotrypsin inhibition (one from each group of diseases), and the serum 
sample  which showed  the  greatest  amount of plasmin  inhibition  (from the 
tuberculosis group)  were studied in the same manner as was normal serum. 
These abnormal sera were tested with the enzyme(s) for which they showed 
increased inhibition. 
In Paper  I  it was shown that the amount of enzyme inhibited by normal 
serum was directly proportional to the amount of serum present.  Sera  with 
abnormally high inhibition gave the  same results.  Heat inactivation of ab- 
normally high inhibition was exactly the same as that/or normal inhibition 
in terms of per cent inhibition remaining after heating undiluted or diluted 
serum. The distribution of inhibition in the various ammonium sulfate frac- 
tions of serum with abnormally high levels of inhibition was the same as that 
of normal serum. Abnormal plasmin inhibition was precipitated at the lower 
concentrations of ammonium sulfate and abnormal trypsin and chymotrypsin 
inhibition was precipitated at the higher concentrations. Thus, no qualitative 
differences were found between normal and abnormal inhibition by the various 
procedures that were carried out. 
DISCUSSION 
The results of the work reported here indicate the existence of more than 
one proteolytic inhibitor in serum. The inhibition of trypsin and chymotrypsin 
by serum  can vary independently from the  inhibition of plasmin,  and  v/ce 
versa. The physical and chemical properties of the trypsin and chymotrypsin 
inhibitor also differ from those of the plasmin inhibitor. No differences were 
found between the inhibitor for trypsin and the inhibitor for chymotrypsin; 
therefore, whatever is said about the trypsin inhibitor in the following discus- 
sion is also true for the chymotrypsin inhibitor. 
The results of differential titration may be interpreted as follows.  Plasmin 
inhibitor and trypsin inhibitor of serum are two distinct substances. Trypsin 602  INHIBITION  OF  PROTEOLYTIC  ENZYMES  BY  SERUM.  II 
inhibitor appears to have no effect on plasmin, but plasmin inhibitor appears 
to inhibit both plasmin and trypsin. Since untreated serum inhibits only about 
10 per cent more trypsin than the same serum after its plasmin inhibitor has 
been neutralized with plasmin, only a  small fraction of the trypsin inhibition 
is due to the plasmin inhibitor. 
Heat inactivation of inhibition gives some support  to  this interpretation. 
At 60°C.  (using whole serum), trypsin inhibition decreased to 10 per cent of 
its original value while plasmin inhibition remained intact. The gradual fur- 
ther decrease in trypsin inhibition was concomitant with, and probably due 
to, the gradual decrease in plasmin inhibition in the 20 to 120 minute period 
(Fig. 4).  Heat inactivation demonstrates the relative lability of trypsin in- 
hibitor compared to plasmin inhibitor in whole serum. The loss of stability of 
plasmin inhibitor after dilution is not an unusual finding, since the heat sta- 
bility of a  protein is frequently dependent upon the protective properties of 
other proteins associated with it (3). Heating also provides evidence for a pos- 
sible third inhibitory factor in serum. A small amount of inhibition for each 
enzyme (approximately 10 per cent for plasmin and approximately 5 per cent 
for trypsin and chymotrypsin) persisted for at least 2 hours when diluted serum 
was heated at 60*C., and it was found to be present (in decreased amounts) 
even after heating for 30 minutes at 100°C. This finding is open to interpre- 
tation: for example, non-specific absorption of the enzymes by serum proteins 
is a possible explanation for the small amount of apparent residual inhibition. 
In ammonium sulfate fractionation of serum it was found that plasmin in- 
hibitor was associated with the globulin fraction, and trypsin inhibitor was 
associated with the albumin fraction. Landsteiner (4) found that the albumin 
fraction of serum prepared by ammonium sulfate precipitation contained most 
of the inhibitory activity for trypsin, and Christensen and MacLeod (5) found 
that it also inhibited plasmin. The latter workers used only the albumin frac- 
tion of serum in studying inhibition. Since the precipitation of both inhibitors 
overlaps to some extent, the observations of Christensen and MacLeod were 
made on the relatively small amount of plasmin inhibitor that is present in 
the albumin fraction. Grob  (6)  studied the inhibition of trypsin and  plasmin 
(and other enzymes) using the various plasma protein fractions of Cohn (7). 
He found that fractions IV-1  and IV-4 accounted for almost all of the inhibi- 
tion of trypsin and that fraction V and, to a slightly less extent, fractions IV-1 
and  IV-4  accounted for the  inhibition of plasmin.  However,  serum protein 
"reconstituted" from the dried protein fractions he used had only 8 to 25 per 
cent of the inhibitory activity of whole serum containing an equal concentra- 
tion of proteins. He was unable to draw any definite conclusions concerning 
the existence of separate proteolytic inhibitors. 
The possibility exists that the specific  increases of inhibition in disease are 
due  to substances not present in normal serum.  In  the various experiments N.  RAPHAEL  SHULMAN  603 
that were done, no qualitative differences were found between inhibitors in 
normal  and  abnormal  serum.  This  favors  the  hypothesis  that  changes  in 
inhibition with disease represent  increases  in normal inhibitors  rather  than 
formation of new and different inhibitors. 
The specificity of serum inhibitors is helpful in explaining the selective re- 
tarding effect of the fibrin substrate on plasmin activity which was shown in 
Paper I. The fibrinogen used in preparing the substrate was obtained from the 
globulin fraction of ammonium sulfate-treated beef plasma. It was shown above 
that the specific  inhibitor of plasmin is also associated with the globulin pre- 
cipitate in ammonium sulfate fractionation of serum. Guest el al. (8) have shown 
that  beef serum  contains approximately the  same  amount of inhibition for 
plasmin as does human serum. Therefore, the inhibitory effect of the substrate 
on plasmin might be accounted for by contamination of the fibrinogen prepara- 
tion with plasmin inhibitor. 
The specificity of inhibition that has been demonstrated suggests that serum 
antiproteolytic factors act in a  more specialized manner than previously sup- 
posed. A fuller understanding of the role of serum inhibitors may be gained by 
attempting to interpret their physiological function in view of the specificity 
of their action. There is as yet no definite information concerning the chemical 
composition of serum  proteolytic inhibitors.  Knowledge of  their  differences 
should be helpful in the eventual isolation of these substances. 
SUMMARY 
Increases  in  serum  proteolytic inhibition with  disease  were  found  to  be 
specific either for plasmin or for trypsin and chymotrypsin. 
In  normal serum,  the  plasmin  inhibitor  could  be  differentiated from the 
trypsin and chymotrypsin inhibitor by various physical and chemical means. 
There  was  no  apparent  difference between  the  trypsin  inhibitor and  the 
chymotrypsin inhibitor in serum. 
No qualitative differences were found between the inhibitors of normal sera 
and the inhibitors of sera showing elevated inhibition. 
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